Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

645640.pdf (58.01 KB)

Document type

Article

Version

Published version

Publication date

2014-03-20

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/121235

Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1200/JCO.2013.54.3033

Subject

Assaigs clínics de medicaments, Càncer de fetge

Subject (English)

Drug testing, Liver cancer

Citation

Collections

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

LLOVET I BAYER, Josep Maria and JOHNSON, Philip J. Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'. Journal of Clinical Oncology. 2014. Vol. 32, num. 9, pags. 968-969. ISSN 0732-183X. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/121235

Export metadata

JSON - METS

Share record